A number of studies have demonstrated that many promising agents are effective on controlling animal sepsis, including low doses of corticosteroids, LPS-target agents and blockers of inflammatory molecules, as well as anti-HMGB1 (high mobility group box 1) antibody and anti-IL-17A antibody [11–14]. Here, HMGB1 is linked to Sepsis.